| Jenna Mary Austin, | |
|
289 County Rd, Windsor, VT 05089-9000 | |
| (802) 674-7437 | |
| Not Available |
| Full Name | Jenna Mary Austin |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 289 County Rd, Windsor, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689455354 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 2988 (New Hampshire) | Secondary |
| 1041C0700X | Social Worker - Clinical | 089.0135322 (Vermont) | Primary |
| Entity Name | Windsor Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841287984 PECOS PAC ID: 2860387214 Enrollment ID: O20040216001074 |
News Archive
Researchers from The University of Texas MD Anderson Cancer Center have developed the first comprehensive framework to classify small-cell lung cancer (SCLC) into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type in a study published today in Cancer Cell.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Older women with breast cancer face a higher risk of being diagnosed with the disease at a late stage, while the risk of an advanced stage diagnosis of lung cancer decreases with age, a new study shows today.
Senate Majority Leader Harry Reid is exempting some of his staff from buying health care coverage on the health law's exchanges, a move the law allows but one that few if any top congressional leadership figures have made.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenna Mary Austin, 528 Old Acworth Stage Rd, Charlestown, NH 03603-4620 Ph: (802) 376-7433 | Jenna Mary Austin, 289 County Rd, Windsor, VT 05089-9000 Ph: (802) 674-7437 |
News Archive
Researchers from The University of Texas MD Anderson Cancer Center have developed the first comprehensive framework to classify small-cell lung cancer (SCLC) into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type in a study published today in Cancer Cell.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Older women with breast cancer face a higher risk of being diagnosed with the disease at a late stage, while the risk of an advanced stage diagnosis of lung cancer decreases with age, a new study shows today.
Senate Majority Leader Harry Reid is exempting some of his staff from buying health care coverage on the health law's exchanges, a move the law allows but one that few if any top congressional leadership figures have made.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.
› Verified 5 days ago
Ms. Janet Farley, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 120 Dairy Ln, Windsor, VT 05089 Phone: 802-674-6065 | |
Anne Marie Kelly, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 82 State St, Windsor, VT 05089 Phone: 860-301-3711 | |
Margaret Swanson, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5 Cherry St, Windsor, VT 05089 Phone: 978-771-2869 | |
Karen D Mcginty, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 141 Etta Frasier Dr, Windsor, VT 05089 Phone: 802-674-9400 | |
Ronald P. Ceppetelli, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 289 County Rd, Windsor, VT 05089 Phone: 802-674-7093 Fax: 802-674-7119 |